Kevin M.  Brady net worth and biography

Kevin Brady Biography and Net Worth

CFO of Medpace
Kevin M. Brady is the CFO & Treasurer at Medpace Inc.

What is Kevin M. Brady's net worth?

The estimated net worth of Kevin M. Brady is at least $2.42 million as of July 31st, 2023. Mr. Brady owns 6,000 shares of Medpace stock worth more than $2,424,900 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Brady may own. Additionally, Mr. Brady receives a salary of $636,580.00 as CFO at Medpace. Learn More about Kevin M. Brady's net worth.

How old is Kevin M. Brady?

Mr. Brady is currently 49 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Kevin M. Brady's age.

What is Kevin M. Brady's salary?

As the CFO of Medpace Holdings, Inc., Mr. Brady earns $636,580.00 per year. There are 4 executives that earn more than Mr. Brady. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,680,000.00 per year. Learn More on Kevin M. Brady's salary.

How do I contact Kevin M. Brady?

The corporate mailing address for Mr. Brady and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at [email protected]. Learn More on Kevin M. Brady's contact information.

Has Kevin M. Brady been buying or selling shares of Medpace?

Kevin M. Brady has not been actively trading shares of Medpace within the last three months. Most recently, Kevin M. Brady sold 7,000 shares of the business's stock in a transaction on Monday, July 31st. The shares were sold at an average price of $255.00, for a transaction totalling $1,785,000.00. Following the completion of the sale, the chief financial officer now directly owns 6,000 shares of the company's stock, valued at $1,530,000. Learn More on Kevin M. Brady's trading history.

Who are Medpace's active insiders?

Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.

Are insiders buying or selling shares of Medpace?

In the last twelve months, insiders at the sold shares 25 times. They sold a total of 841,430 shares worth more than $246,456,813.05. The most recent insider tranaction occured on March, 15th when VP Susan E Burwig sold 102 shares worth more than $41,106.00. Insiders at Medpace own 25.7% of the company. Learn More about insider trades at Medpace.

Information on this page was last updated on 3/15/2024.

Kevin M. Brady Insider Trading History at Medpace

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/31/2023Sell7,000$255.00$1,785,000.006,000View SEC Filing Icon  
11/2/2021Sell1,250$226.50$283,125.00View SEC Filing Icon  
See Full Table

Kevin M. Brady Buying and Selling Activity at Medpace

This chart shows Kevin M Brady's buying and selling at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medpace Company Overview

Medpace logo
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Read More

Today's Range

Now: $404.15
Low: $401.76
High: $407.14

50 Day Range

MA: $366.45
Low: $291.58
High: $413.31

2 Week Range

Now: $404.15
Low: $181.50
High: $419.42

Volume

197,391 shs

Average Volume

260,472 shs

Market Capitalization

$12.43 billion

P/E Ratio

45.51

Dividend Yield

N/A

Beta

1.38